Loading asset research
Medicus Pharma Ltd. Common Stock
MDCXNasdaq · USD · StocksQuote as of · Exchange session not verified$0.1617
+0.43%
Today
MDCX
Loading 1D prices…
Market cap
$10.3M
Volume
3.5M
52w high
$3.0552w low
$0.151Company profile
Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. The company has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in West Conshohocken, Pennsylvania.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
West Conshohocken, PA, United States
Employees
16
Fiscal year end
1231
CIK
1997296
Session & valuation
Open$0.157
Previous close$0.161
Day high$0.163
Day low$0.154
30-day avg. volume6.7M
Outstanding shares63.2M
Diluted EPS-$2.74
Latest annual period
P/E (trailing)-0.06
P/E (forward)-0.34
Price / book-5.61
Beta-0.48
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| VTGNVistagen Therapeutics Inc. Common Stock | $10.5M | $1.3M | -5491.88% | -$1.83 | 0.00% | Hold |
| FBLGFibroBiologics Inc. Common Stock | $10.7M | $0.00 | — | -$0.42 | -6.94% | Buy |
| LNAILunai Bioworks Inc. Common Stock | $10.8M | $20.9K | -7409.88% | -$0.07 | -2.26% | Unrated |
| AZTRAzitra Inc Common Stock | $10.8M | $0.00 | — | -$2.25 | -1.11% | Buy |
| APREAprea Therapeutics Inc. Common stock | $9.7M | $0.00 | — | -$1.93 | -1.90% | Buy |